Literature DB >> 19383433

Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Lakshmi Thirumangalakudi1, Haripriya Vittal Rao, Paula Grammas.   

Abstract

The pathways that contribute to thrombin-induced neuron death have been incompletely defined. Induction of cyclooxygenase 2 (COX-2), the enzyme that catalyzes the first step in prostaglandin synthesis, promotes neuronal injury. PGE2, a downstream product of COX-2 metabolism, is neurotoxic in vitro and in vivo, and is thought to be the bioactive mediator responsible for COX-2 neurotoxicity. The objective of this study is to determine the ability of thrombin to affect PGE2 metabolism in cultured neurons. The data show that in thrombin-induced apoptosis of cultured neurons, PGE2 release increases when COX-2 is absent, and is regulated by prostaglandin dehydrogenase (PGDH), a key enzyme that degrades PGE2. NS398, a COX-2 specific inhibitor, protects neurons against thrombin toxicity, by inducing active PGDH. These data implicate PGDH in thrombin-mediated neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383433      PMCID: PMC2727552          DOI: 10.1016/j.neulet.2009.01.045

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  46 in total

1.  Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons.

Authors:  Haripriya Vittal Rao; Lakshmi Thirumangalakudi; Paula Desmond; Paula Grammas
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

2.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.

Authors:  S J Hewett; T F Uliasz; A S Vidwans; J A Hewett
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

3.  Mechanisms of cell death in primary cortical neurons and PC12 cells.

Authors:  U Reimann-Philipp; R Ovase; P H Weigel; P Grammas
Journal:  J Neurosci Res       Date:  2001-06-15       Impact factor: 4.164

4.  Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity.

Authors:  E Araki; C Forster; J M Dubinsky; M E Ross; C Iadecola
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

5.  Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture.

Authors:  Wenjin Li; Shasha Wu; Robert W Hickey; Marie E Rose; Jun Chen; Steven H Graham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

6.  The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus.

Authors:  T Kunz; E H Oliw
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

7.  Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

Authors:  Zhenxiong Liu; Xin Wang; Yuanyuan Lu; Shuang Han; Faming Zhang; Huihong Zhai; Ting Lei; Jie Liang; Jun Wang; Kaichun Wu; Daiming Fan
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

8.  Effect of calcium ionophore A23187 on prostaglandin synthase type 2 and 15-hydroxy-prostaglandin dehydrogenase expression in human chorion trophoblast cells.

Authors:  Valentina Casciani; Marina Premyslova; Daochun Luo; Emanuela Marinoni; Massimo Moscarini; Romolo Di Iorio; John R G Challis
Journal:  Am J Obstet Gynecol       Date:  2008-07-17       Impact factor: 8.661

9.  PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.

Authors:  Emilce Carrasco; Diana Casper; Peter Werner
Journal:  J Neurosci Res       Date:  2007-11-01       Impact factor: 4.164

10.  Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.

Authors:  Naoki Wakimoto; Ido Wolf; Dong Yin; James O'Kelly; Tadayuki Akagi; Lilach Abramovitz; Keith L Black; Hsin-Hsiung Tai; H Phillip Koeffler
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

View more
  7 in total

1.  Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.

Authors:  D Isaev; I Lushnikova; O Lunko; O Zapukhliak; O Maximyuk; A Romanov; G G Skibo; C Tian; G L Holmes; E Isaeva
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

2.  Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.

Authors:  Frieder Schlunk; Elena Schulz; Arne Lauer; Kazim Yigitkanli; Waltraud Pfeilschifter; Helmuth Steinmetz; Eng H Lo; Christian Foerch
Journal:  Transl Stroke Res       Date:  2014-11-27       Impact factor: 6.829

3.  Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.

Authors:  Xiaoning Han; Xi Lan; Qiang Li; Yufeng Gao; Wei Zhu; Tian Cheng; Takayuki Maruyama; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

4.  Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia.

Authors:  Q Xia; Q Hu; H Wang; H Yang; F Gao; H Ren; D Chen; C Fu; L Zheng; X Zhen; Z Ying; G Wang
Journal:  Cell Death Dis       Date:  2015-03-26       Impact factor: 8.469

5.  Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System.

Authors:  Chin Wai Hui; Yang Zhang; Karl Herrup
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

6.  Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome.

Authors:  Ameer Y Taha; Fei Gao; Epolia Ramadan; Yewon Cheon; Stanley I Rapoport; Hyung-Wook Kim
Journal:  BMC Neurosci       Date:  2012-10-30       Impact factor: 3.288

7.  Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.

Authors:  Bruce A Citron; Syed Ameenuddin; K Uchida; William Z Suo; Karen SantaCruz; Barry W Festoff
Journal:  Brain Res       Date:  2016-04-30       Impact factor: 3.610

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.